-
1
-
-
36148996924
-
Guidelines for evaluation and management of urticaria in adults and children
-
Grattan CE, Humphreys F. Guidelines for evaluation and management of urticaria in adults and children. Br J Dermatol 2007; 157: 1116-1123.
-
(2007)
Br J Dermatol
, vol.157
, pp. 1116-1123
-
-
Grattan, C.E.1
Humphreys, F.2
-
2
-
-
0031058238
-
The impact of chronic urticaria on the quality of life
-
O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 197-201.
-
(1997)
Br J Dermatol
, vol.136
, pp. 197-201
-
-
O'Donnell, B.F.1
Lawlor, F.2
Simpson, J.3
Morgan, M.4
Greaves, M.W.5
-
3
-
-
43449123325
-
Therapeutic alternatives for chronic urticaria: An evidence-based review, part 1
-
Morgan M, Khan DA. Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1. Ann Allergy Asthma Immunol 2008; 100: 403-411.
-
(2008)
Ann Allergy Asthma Immunol
, vol.100
, pp. 403-411
-
-
Morgan, M.1
Khan, D.A.2
-
4
-
-
45149086027
-
Therapeutic alternatives for chronic urticaria: An evidence-based review, part 2
-
Morgan M, Khan DA. Therapeutic alternatives for chronic urticaria: an evidence-based review, Part 2. Ann Allergy Asthma Immunol 2008; 100: 517-526. (Pubitemid 351829849)
-
(2008)
Annals of Allergy, Asthma and Immunology
, vol.100
, Issue.6
, pp. 517-526
-
-
Morgan, M.1
Khan, D.A.2
-
5
-
-
0017746348
-
Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1r-, and C1 esterase
-
Tamura Y, Hirado M, Okamura K, Minato Y, Fujii S. Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1r-, and C1 esterase. Biochim Biophys Acta 1977; 484: 417-422.
-
(1977)
Biochim Biophys Acta
, vol.484
, pp. 417-422
-
-
Tamura, Y.1
Hirado, M.2
Okamura, K.3
Minato, Y.4
Fujii, S.5
-
6
-
-
0021265581
-
Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments
-
Aoyama T, Ino Y, Ozeki M, Oda M, Sato T, Koshiyama Y, et al. Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments. Jpn J Pharmacol 1984; 35: 203-227.
-
(1984)
Jpn J Pharmacol
, vol.35
, pp. 203-227
-
-
Aoyama, T.1
Ino, Y.2
Ozeki, M.3
Oda, M.4
Sato, T.5
Koshiyama, Y.6
-
7
-
-
33745455885
-
Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma
-
Chen CL, Wang SD, Zeng ZY, Lin KJ, Kao ST, Tani T, et al. Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma. J Allergy Clin Immunol 2006; 118: 105-112.
-
(2006)
J Allergy Clin Immunol
, vol.118
, pp. 105-112
-
-
Chen, C.L.1
Wang, S.D.2
Zeng, Z.Y.3
Lin, K.J.4
Kao, S.T.5
Tani, T.6
-
8
-
-
0037353099
-
A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium
-
Sendo T, Itoh Y, Goromaru T, Sumimura T, Saito M, Aki K, et al. A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium. Br J Pharmacol 2003; 138: 959-967.
-
(2003)
Br J Pharmacol
, vol.138
, pp. 959-967
-
-
Sendo, T.1
Itoh, Y.2
Goromaru, T.3
Sumimura, T.4
Saito, M.5
Aki, K.6
-
9
-
-
33847420567
-
Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria
-
Asero R, Tedeschi A, Coppola R, Griffini S, Paparella P, Riboldi P, et al. Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. J Allergy Clin Immunol 2007; 119: 705-710.
-
(2007)
J Allergy Clin Immunol
, vol.119
, pp. 705-710
-
-
Asero, R.1
Tedeschi, A.2
Coppola, R.3
Griffini, S.4
Paparella, P.5
Riboldi, P.6
-
10
-
-
0032839469
-
Complement dependence of histamine release in chronic urticaria
-
Ferrer M, Nakazawa K, Kaplan AP. Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol 1999; 104: 169-172.
-
(1999)
J Allergy Clin Immunol
, vol.104
, pp. 169-172
-
-
Ferrer, M.1
Nakazawa, K.2
Kaplan, A.P.3
-
11
-
-
0014458845
-
Use of a kallikrein inhibitor in the treatment of urticaria and hereditary angioneurotic edema
-
Juhlin L, Michaelsson G. Use of a kallikrein inhibitor in the treatment of urticaria and hereditary angioneurotic edema. Acta Derm Venereol 1969; 49: 37-44.
-
(1969)
Acta Derm Venereol
, vol.49
, pp. 37-44
-
-
Juhlin, L.1
Michaelsson, G.2
-
12
-
-
0016167068
-
Treatment of chronic urticaria with a proteinase (kallikrein) inhibitor
-
Berova N, Petkov I, Andreev VC. Treatment of chronic urticaria with a proteinase (kallikrein) inhibitor. Br J Dermatol 1974; 90: 431-434.
-
(1974)
Br J Dermatol
, vol.90
, pp. 431-434
-
-
Berova, N.1
Petkov, I.2
Andreev, V.C.3
-
13
-
-
0142183301
-
Protease inhibitors in the treatment of hereditary angioedema
-
Ritchie BC. Protease inhibitors in the treatment of hereditary angioedema. Transfus Apher Sci 2003; 29: 259-267.
-
(2003)
Transfus Apher Sci
, vol.29
, pp. 259-267
-
-
Ritchie, B.C.1
|